KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Equity Ratio: 2017-2025

Historic Equity Ratio for Moderna (MRNA) over the last 7 years, with Sep 2025 value amounting to 0.77.

  • Moderna's Equity Ratio rose 1.87% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year increase of 1.87%. This contributed to the annual value of 0.77 for FY2024, which is 2.52% up from last year.
  • According to the latest figures from Q3 2025, Moderna's Equity Ratio is 0.77, which was down 1.76% from 0.78 recorded in Q2 2025.
  • Over the past 5 years, Moderna's Equity Ratio peaked at 0.79 during Q1 2025, and registered a low of 0.30 during Q1 2021.
  • Over the past 3 years, Moderna's median Equity Ratio value was 0.77 (recorded in 2025), while the average stood at 0.76.
  • In the last 5 years, Moderna's Equity Ratio crashed by 61.91% in 2021 and then skyrocketed by 104.55% in 2022.
  • Quarterly analysis of 5 years shows Moderna's Equity Ratio stood at 0.57 in 2021, then grew by 28.98% to 0.74 in 2022, then grew by 1.67% to 0.75 in 2023, then climbed by 2.52% to 0.77 in 2024, then climbed by 1.87% to 0.77 in 2025.
  • Its Equity Ratio was 0.77 in Q3 2025, compared to 0.78 in Q2 2025 and 0.79 in Q1 2025.